AQR Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

AQR Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-96,027	Closed	-$4.51M	–	3588
2025 Q2	$4.51M	Buy	96,027 +31,291	+48%	+$1.39M	﹤0.01%	1344
2025 Q1	$2.86M	Buy	64,736 +43,855	+210%	+$2.02M	﹤0.01%	1413
2024 Q4	$754K	Sell	20,881 -23,075	-52%	-$806K	﹤0.01%	2045
2024 Q3	$1.41M	Buy	43,956 +6,543	+17%	+$244K	﹤0.01%	1674
2024 Q2	$1.41M	Buy	37,413 +18,017	+93%	+$758K	﹤0.01%	1609
2024 Q1	$955K	Buy	+19,396	New	+$897K	﹤0.01%	1714
2021 Q4	–	Sell	-7,258	Closed	-$460K	–	2276
2021 Q3	$460K	Buy	7,258 +1,761	+32%	+$136K	﹤0.01%	1894
2021 Q2	$453K	Buy	5,497 +1,455	+36%	+$110K	﹤0.01%	1936
2021 Q1	$297K	Buy	+4,042	New	+$317K	﹤0.01%	2010

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

AQR Capital Management's SWTX Position: Q3 2025 in Review

AQR Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 96,027 shares — an estimated $4.51M sold.

AQR Capital Management first reported a position in SWTX in Q1 2021 and held it in 9 quarters. The position peaked at $4.51M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

AQR Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
AQR Capital Management sold 96,027 SpringWorks Therapeutics shares in Q3 2025, an estimated $4.51M.
AQR Capital Management first reported a position in SpringWorks Therapeutics in Q1 2021 and held it in 9 quarters.
AQR Capital Management's SpringWorks Therapeutics position peaked at $4.51M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.